Literature DB >> 18393360

c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.

Vidyalakshmi Chandramohan1, Nora D Mineva, Brian Burke, Sébastien Jeay, Min Wu, Jian Shen, William Yang, Stephen R Hann, Gail E Sonenshein.   

Abstract

The p27(Kip1) (p27) cyclin-dependent kinase inhibitor and c-Myc oncoprotein play essential roles in control of cell cycle progression and apoptosis. Induction of p27 (CDKN1B) gene transcription by Forkhead box O proteins such as FOXO3a leads to growth arrest and apoptosis. Previously, we observed that B cell receptor (surface IgM) engagement of WEHI 231 immature B lymphoma cells with an anti-IgM antibody results in activation of FOXO3a, growth arrest and apoptosis. As ectopic c-Myc expression in these cells prevented anti-IgM induction of p27 and cell death, we hypothesized that c-Myc represses FOXO3a-mediated transcription. Here we show that c-Myc inhibits FOXO3a-mediated activation of the p27 promoter in multiple cell lines. The mechanism of this repression was explored using a combination of co-immunoprecipitation, oligonucleotide precipitation, and chromatin immunoprecipitation experiments. The studies demonstrate a functional association of FOXO3a and c-Myc on a proximal Forkhead binding element in the p27 promoter. This association involves the Myc box II domain of c-Myc and the N-terminal DNA-binding portion of FOXO3a. Analysis of publicly available microarray datasets showed an inverse pattern of c-MYC and p27 RNA expression in primary acute myeloid leukemia, prostate cancer and tongue squamous cell carcinoma samples. The inhibition of FOXO3a-mediated activation of the p27 gene by the high aberrant expression of c-Myc in many tumor cells likely contributes to their uncontrolled proliferation and invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393360     DOI: 10.1002/jcb.21765

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  30 in total

1.  Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.

Authors:  Kamonwan Fish; Jia Chen; Richard Longnecker
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

2.  FOXO3a: A Potential Target in Prostate Cancer.

Authors:  Sanjeev Shukla
Journal:  Austin J Urol       Date:  2014

3.  MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.

Authors:  Gianpiero Di Leva; Pierluigi Gasparini; Claudia Piovan; Apollinaire Ngankeu; Michela Garofalo; Cristian Taccioli; Marilena V Iorio; Meng Li; Stefano Volinia; Hansjuerg Alder; Tatsuya Nakamura; Gerard Nuovo; Yunlong Liu; Kenneth P Nephew; Carlo M Croce
Journal:  J Natl Cancer Inst       Date:  2010-04-13       Impact factor: 13.506

4.  FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function.

Authors:  Kim Steen Jensen; Tina Binderup; Klaus Thorleif Jensen; Ib Therkelsen; Rehannah Borup; Elise Nilsson; Hinke Multhaupt; Caroline Bouchard; Bjørn Quistorff; Andreas Kjaer; Göran Landberg; Peter Staller
Journal:  EMBO J       Date:  2011-11-16       Impact factor: 11.598

5.  Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.

Authors:  Biswajyoti Sahu; Marko Laakso; Kristian Ovaska; Tuomas Mirtti; Johan Lundin; Antti Rannikko; Anna Sankila; Juha-Pekka Turunen; Mikael Lundin; Juho Konsti; Tiina Vesterinen; Stig Nordling; Olli Kallioniemi; Sampsa Hautaniemi; Olli A Jänne
Journal:  EMBO J       Date:  2011-09-13       Impact factor: 11.598

6.  Artemis interacts with the Cul4A-DDB1DDB2 ubiquitin E3 ligase and regulates degradation of the CDK inhibitor p27.

Authors:  Yiyi Yan; Xiaoshan Zhang; Randy J Legerski
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

7.  Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.

Authors:  Yu Tao; Zhanjie Liu; Yingyong Hou; Shouli Wang; Sanhong Liu; Yuhang Jiang; Dan Tan; Qiulin Ge; Cuifeng Li; Yiming Hu; Zhi Liu; Xi Chen; Qi Wang; Mingliang Wang; Xiaoren Zhang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

8.  Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.

Authors:  Jiansheng Huang; Andrew E Schriefer; Wei Yang; Paul F Cliften; David A Rudnick
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.